Wed, 16 Jun 2021 10:10:22: Kahr reels in $47M to fund CD47 trial, work on TIGIT prospect

Tue, 15 Jun 2021 16:49:07: Evotec wants to prevent the next COVID-19 crisis, and you could help

Tue, 15 Jun 2021 09:53:38: VectorY raises $38M to develop Alzheimer's, ALS gene therapies

Tue, 15 Jun 2021 09:13:59: AstraZeneca's COVID-19 antibody combination fails post-exposure prevention trial

Mon, 14 Jun 2021 15:20:26: Diabetes mainstay metformin tamps down lung inflammation in COVID models

Mon, 14 Jun 2021 09:39:02: EHA: Epizyme's first-in-class multiple myeloma drug candidate inhibits tumors in mice

Mon, 14 Jun 2021 08:56:29: GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race

Mon, 14 Jun 2021 07:50:59: Novavax COVID-19 vaccine hits 90% efficacy in pivotal U.S. trial

Fri, 11 Jun 2021 10:37:19: Sanofi's treatment for rare anemia hits goal in 2nd phase 3

Fri, 11 Jun 2021 08:52:37: Harvard's Kesselheim quits AdComm over FDA's Aduhelm approval

Fri, 11 Jun 2021 08:24:51: Eli Lilly, Roche's Alzheimer's prospects, including flops, boosted in light of FDA's Aduhelm approval: analysts

Thu, 10 Jun 2021 19:02:17: Chutes & Ladders—FDA nod for Biogen's Aduhelm sees trio of AdComm members hit the exit

Thu, 10 Jun 2021 13:18:58: Acumen rides aducanumab, amyloid and Alzheimer's waves on its IPO voyage

Thu, 10 Jun 2021 12:05:11: Kurome raises $15M to overcome adaptive resistance in leukemia

Thu, 10 Jun 2021 09:55:28: AdComm exodus: 2nd expert quits over FDA approval of Biogen's Aduhelm

Wed, 09 Jun 2021 14:24:36: Old antidepressants show promise as immuno-oncology treatments in melanoma and colon cancer

Wed, 09 Jun 2021 12:14:15: Kojin bags $60M to exploit weakness of drug-resistant cancers

Wed, 09 Jun 2021 10:08:21: AdComm member quits over FDA approval of Biogen's Aduhelm

Wed, 09 Jun 2021 09:52:29: Making drug-resistant bacteria susceptible to antibiotics

Wed, 09 Jun 2021 09:35:35: Editor's Corner—The FDA's decision on aducanumab will drag down innovation for years to come

Wed, 09 Jun 2021 02:10:12: AbbVie snags another preclinical Parkinson's program with $17M Caraway pact

Tue, 08 Jun 2021 13:30:00: Bayer's billon-dollar Parkinson's disease bets land in the clinic

Tue, 08 Jun 2021 12:22:14: Seagen joins SpringWorks' long list of BCMA combo partners

Tue, 08 Jun 2021 12:17:45: Graphite files for $100M IPO to fund push to cure sickle cell

Mon, 07 Jun 2021 13:46:51: ASCO: Alpine reports 61% 'clinical benefit' in early trial of CD28-targeted immuno-oncology drug